Drug Trial Radar · NCT04397562
A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19
Last checked: Nov 19, 2026Latest source record: Nov 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
206
Actual
Start
Apr 29, 2020
Primary completion
Jul 3, 2020
Study completion Aug 3, 2020
Sponsor
- Lead sponsor
- BiocadIndustry
- Sponsor type
- Industry
- First posted
- May 21, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective: to study the efficacy and safety of levilimab in subjects with severe COVID-19.
Conditions
- COVID-19
Interventions
LevilimabDrug
Levilimab 324 mg
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of patients with sustained clinical recoveryTime frame: Day 14
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
State Budgetary Healthcare Institution Kaluga region "Kaluga Regional Clinical Hospital"
Kaluga, Russia
State Budget Institution of the Republic of Dagestan "Republican Clinical Hospital"
Makhachkala, Russia
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery
Moscow, Russia
City Clinical Hospital No. 40 of the Department of Health of the city of Moscow
Moscow, Russia
City Clinical Hospital No.52
Moscow, Russia
City Clinical Hospital № 15 named. O.M. Filatov
Moscow, Russia
City Clinical Hospital №1 named after N.I. Pirogov, Moscow City Health Department
Moscow, Russia
Federal State Budgetary Institution "Central Clinical Hospital with Clinic", Office of the President of the Russian Federation
Moscow, Russia
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Moscow, Russia
Pirogov Russian National Research Medical University
Moscow, Russia
Railway clinical hospital named after N.A. Semashko
Moscow, Russia
Almazov National Medical Research Centre
Saint Petersburg, Russia
Clinical Infectious Disease Hospital named after S.P. Botkin
Saint Petersburg, Russia
North-western State Medical University named after I.I.Mechnikov
Saint Petersburg, Russia
Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry of Healthcare of the Russian Federation
Ufa, Russia
Federal State Budgetary Educational Institution of Higher Education "North Ossetian State Medical Academy" of the Ministry of Health of the Russian Federation (FSBEI HE SOGMA of the Ministry of Health of Russia)
Vladikavkaz, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.